Foster common approaches between People’s Republic of China and the European Union on Personalised Medicine research, development, innovation and policies
News
ICPerMed Conference 2020 ‘Personalised Medicine – From Vision to Practice’, Paris , February 25-26, 2021
Next ICPerMed bi-annual Conference will take place in 2021, due to the COVID-19 outbreak. This event will focus [...]
IC2PerMed project’s launch
IC2PerMed started on January 1rst, 2020. Get to know the background of this project, its objectives, partners and [...]
IC2PerMed at a glance
Supporting International collaboration for the development of Personalised Medicine
The International Consortium for Personalised Medicine (ICPerMed), umbrella initiative of IC2PerMed, aims at initiating and supporting communication and exchange on Personalised Medicine (PM) for aligning national agendas on research and funding activities. It brings together representatives of funding agencies and authorities from 29 countries and expands for increasing PM developments’ synergies at international level.
IC2PerMed project’s core objective is to build upon collaborative developments of Chinese and European experts on PM for elaborating a common strategy, enabling Chinese institutions to join the ICPerMed consortium. The 3 Expert Working Groups will set the path for a common approach of PM research, innovation, development and implementation over the project duration.
